Tetrhydroisoquinoline derivatives, pharmaceutical compositions comprising them and methods of treating disease are disclosed herein. The disclosed compounds are useful in the treatment and prevention of diseases mediated by chloride channel activity and/or protein trafficking, including, but not limited to, diseases associated with impaired mucociliary clearance such as cystic fibrosis, bronchitis, emphysema, and the like.
本文披露了
四氢异喹啉衍
生物、包含它们的药物组合物以及治疗疾病的方法。所披露的化合物在治疗和预防由
氯离子通道活性和/或蛋白质运输介导的疾病方面是有用的,包括但不限于与黏液纤毛清除受损有关的疾病,如囊性纤维化、支气管炎、肺气肿等。